University of British Columbia
Utilization of a novel mutli-cell type neurosphere system to investigate APOE2, APOE3, APOE4, and APOE3Ch reveals genotype-specific responses to amyloid pathology
Abstract
dc:descriptionAlzheimer’s disease (AD), the leading cause of dementia, is characterized by progressive neurodegeneration and cognitive decline. AD cases are classified into familial (fAD) and sporadic (sAD) types, with the latter constituting the majority. The APOE gene – encoding apolipoprotein E (ApoE), is the most significant genetic risk factor for sAD, with the APOE4 allele conferring increased risk compared to the neutral APOE3, and APOE2 conferring protection. With global prevalence of AD expected to rise to 139 million by 2050, creating more accurate disease models for understanding the mechanisms behind disease progression and drug discovery represents an urgent challenge. Developments in 3D cellular models offer a physiologically relevant platform to study AD pathology; such processes include amyloid-β (Aβ) neurotoxicity, microglial inflammation, and synaptic dynamics. Neurospheres are self- or forced-assembled aggregates of neural cells that generally lack exogenous scaffolds and are cultured in 2D or suspended in media. When compared to other methods of engineering 3D neural tissue – such as organoids or hydrogels – neurospheres have the advantage of requiring fewer resources, less expertise, and higher scalability, at the cost of decreased physiological complexity. In this dissertation, we aimed to investigate APOE utilizing a novel 3D neurosphere system incorporating neurons, astrocytes, and microglia. We first validated our neurosphere system, demonstrating robust spontaneous neural network activity and susceptibility to oligomeric Aβ-induced functional decline. We then generated and characterized neurospheres isogenic for homozygous APOE2, APOE3, APOE4, and APOE3Ch genotypes – the last being a rare APOE protective variant – and subjected them to a chronic oligomeric Aβ treatment paradigm. Neurospheres displayed genotype-dependent resistance to Aβ-induced functional decline mirroring the clinical risk hierarchy of ApoE2 > ApoE3 ≈ ApoE3Ch > ApoE4. Introduction of isogenic APOE microglia revealed a genotype-dependent infiltration rate that matched the clinical condition, and microglia demonstrated partial capacity to halt or reverse functional decline. Finally, bulk RNA sequencing of isogenic APOE neurospheres revealed a genome-wide failure of ApoE4 neurospheres to transcriptionally respond to oligomeric Aβ, while ApoE2 neurospheres mounted a coordinated multi-arm protective program. Collectively, this work establishes a human 3D neurosphere platform as a tool for investigating APOE-dependent mechanisms in AD and advancing therapeutic discovery.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Medicine / Doctor of Philosophy - MD/PhD
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Neuroscience
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Lee, Christopher
- Contributors dc:contributor
-
- Nygaard, Haakon B.
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/95552